Bayer launches contrast agent injector

Bayer (ETR:BAYN) yesterday said that it has launched its Medrad Stellant Flex CT injection system.

Stellant Flex is a user-driven system that requires minimal technologist training and automation, according to Whippany, N.J.-based Bayer U.S. It offers individualized patient protocols and personalized imaging with flexible options for capital equipment through the company’s TechCare program.

“For more than 30 years, Bayer has supported the changing needs of radiology department through groundbreaking advancements in injector, informatics and service innovations, ultimately allowing for improved patient care,” head of Bayer Radiology in the Americas Dennis Durmis said in a news release. “The automated capture of contrast and injection parameters with Stellant Flex reduces the number of manual tasks and potential errors, while TechCare allows radiology suites to maximize their CT equipment investment for the long term, giving them more time to focus on helping their patients and less time focused on equipment servicing.”

Stellant Flex was designed to drive efficiencies, with 150 mL and 20 mL syringe sizes, new technology for fluid visualization, syringe-size barcode identification, lot and expiry date information, increased accuracy and automation of documentation with contrast barcode reader and a streamlined training program.

Bayer said it will offer service coverage with two hardware upgrades over the course of a three-year contract to prevent hardware obsolescence.